Wondering if the commute by bike is worth it? The benefits of cycling to work are best documented for health: large studies link it to a lower risk of early death. Here is what the evidence shows.
This guide sits within the wider topic of urban cycling mobility.
| Item | Value |
|---|---|
| Lower risk of dying overall, UK cycle commuters vs car or public transport commuters | 41% lower |
| Lower risk of dying from heart disease, UK cycle commuters | 52% lower |
| Lower risk of dying from cancer, UK cycle commuters | 40% lower |
| UK adults tracked in the study | 263,450 over five years |
| Reduction in mortality, New Zealand cycle commuters | 13 per cent |
| People in the New Zealand data | 3.5 million |
The figures come from a Streetsblog USA report from April 2017 and a ScienceDaily summary from January 2020. Research figures can change as studies are updated, so check the sources before you rely on them.
What the large UK study found
The most widely cited evidence is a study published in the British Medical Journal in 2017. It tracked 263,450 adults from England, Scotland and Wales over five years, comparing cycle commuters with people who drove or took public transport.
Compared with those other commuters, people who cycled to work had:
- a 41% lower risk of dying overall;
- a 52% lower risk of dying from heart disease;
- a 40% lower risk of dying from cancer;
- a 46% lower risk of developing heart disease and a 45% lower risk of developing cancer at all.
The researchers adjusted for sex, age, deprivation, ethnicity, smoking, body mass index, other physical activity, time spent sitting and diet. Even so, the study shows an association and does not prove that cycling caused the difference.
Results were smaller but still positive for people who mixed cycling with driving or transit. That group had a 24% lower risk of death, including a 36% lower risk of dying from cancer.
What the New Zealand study found
A separate census-based study in New Zealand, published in the International Journal of Epidemiology, reached a similar conclusion. People who cycled to work had a 13 per cent reduction in mortality, which the lead researcher said was likely a result of the health benefits of physical activity.
The team linked census and mortality records for 3.5 million people. Lead researcher Dr Caroline Shaw said the data covered 80 per cent of the working-age population over a 15-year period, following the 1996, 2001 and 2006 censuses.

Cycling was rare in that data. More than 80 per cent of people travelled to work by car, five per cent walked and three per cent cycled, with two per cent of women cycling compared with four per cent of men.
One limit is worth knowing. The census gave no details about the physical intensity of the commute, so a gentle short ride and a hard hilly one counted the same.
How cycling compares with walking and public transport
The two studies do not treat other modes identically. In the UK study, people who walked to work saw some benefit through a reduced risk of developing and dying from heart disease, but not a reduced risk of all types of mortality.
In New Zealand, there was no reduction in mortality for people who walked or took public transport to work. Dr Shaw added that walking has other physical-activity-related benefits, including preventing cardiovascular disease and diabetes, and that public transport emits less carbon.
So the evidence supports cycling as a strong option for health, without making other ways of getting to work a poor choice.
Safety and the role of infrastructure
Safety is a common worry, so it helps that the New Zealand researchers saw no increase in road traffic injury deaths linked to walking and cycling. They noted that the transport system at the time was heavily car-dominated and roads seldom made allowances for pedestrians and cyclists.
Both research groups point to the street itself. Dr Shaw said increasing commuter cycling would need policies on transport and urban planning, such as implementing cycling networks, and the UK authors wrote that investment in bike-share and bike lanes offers major opportunities for public health.
If you want to see what separated space looks like, our guide to protected bike lanes explains the basics.
Cost and time: what the evidence covers
The studies above measured health outcomes, not money or journey time. Any saving on fuel, fares, parking or travel time depends on your own route, so it is better to test it than to trust a headline number.
A simple way to do that:
- Note the door-to-door time and the weekly cost of your current commute.
- Ride your route once on a quiet day and time it.
- Compare the two, including parking, fares and fuel you would no longer pay for.
- Plan where the bike will be parked at work, and read up on how to lock a bike securely before you commit.
Our short explainer on how to lock a bike covers the last step.
Frequently asked questions
Does cycling to work really help you live longer?
Show answer
Large studies in the UK and New Zealand link cycle commuting with lower mortality. They show an association rather than proof of cause, so treat the results as strong evidence and not a guarantee.
Do you have to cycle the whole way?
Show answer
No. In the UK study, people who combined cycling with a driving or transit commute had a 24% lower risk of death, smaller than for full cycle commuters but still lower.
Is cycling better than walking for commuting health?
Show answer
In both studies cycling showed the broader mortality link. The UK study found walking linked to lower heart disease risk, and the New Zealand study found no mortality reduction for walkers.
Is cycling to work dangerous?
Show answer
The New Zealand study saw no increase in road traffic injury deaths linked to cycling, even on car-dominated roads. Safer street design is still the main lever the researchers recommend.



